Strategy for the Next few MonthsI would suggest to all to best utilize the the next few months as follows:
1) take gains out of your TFSA a/c in stock you hold (other than TLT shares) in the 2022 tax year.
2) transfer those proceeds to your bank account. Spend that money or recontribute that amount to your margin a/c.
3) if you currently have TLT stock in your margin a/c, do a specie "in kind" transfer of TLT stock from your margin account to your TFSA a/c in the 2023 tax year in the same amount as what was withdrawn in 2022. You are allowed to do this in the following year after the withdrawl year.
4) in the new 2023 tax year, also transfer in the allowable cash contribution to your TFSA a/c and buy TLT stock or again do a specie "in kind" transfer of TLT shares from your margin a/c to your TFSA a/c based upon the price on the day you execute this transaction in 2023.
This will probably be your last chance to move and protect as many TLT shares as possible in your (tax exempt) TFSA a/c. Once BTD/AA application is made (likely mid to end of December 2022), the FDA will respond to Theralase in 60 days (say mid Feb 2023) on whether or not BTD/AA is granted. If granted, TLT stock goes parabolic. Pharmas circle. Any capital gains on a takeout/JV/etc will be protected from taxation in your TFSA. Then enjoy the rest of your life !!!!